ASPIRE BIOPHARMA HOLDINGS, INC. Cost of Revenue
ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) reported Cost of Revenue of $50.82 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-13
- ASPIRE BIOPHARMA HOLDINGS, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $50.82K.
- ASPIRE BIOPHARMA HOLDINGS, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $22.60K.
- ASPIRE BIOPHARMA HOLDINGS, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $5.26K.
- ASPIRE BIOPHARMA HOLDINGS, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $1.06K.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $50.82K 10-Q · filed 2026-08-13 | $73.42K 10-Q · filed 2026-08-13 | $78.68K derived: sum of 3 quarters · filed 2026-08-13 | $79.74K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $22.60K 10-Q · filed 2026-05-15 | $27.86K derived: sum of 2 quarters · filed 2026-05-15 | $28.92K derived: sum of 3 quarters · filed 2026-05-15 | |
| 2025-12-31 | $5.26K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-04-10 | $6.32K derived: sum of 2 quarters · filed 2026-04-10 | $6.32K S-1/A · filed 2026-04-10 | |
| 2025-09-30 | $1.06K 10-Q · filed 2025-11-14 | $1.06K 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |